A
Avinger
Designs, develops and manufactures precision medical device technology
About Avinger
Avinger, Inc. is a medical device company specializing in the treatment of vascular diseases, particularly focusing on peripheral artery disease (PAD). The company operates in the healthcare sector, targeting hospitals, clinics, and medical professionals who treat vascular conditions. Avinger's core product is its Lumivascular technology, which integrates onboard image guidance to enhance the precision and safety of vascular procedures. This technology is designed to treat small vessel diseases, especially below the knee, offering a minimally invasive solution that improves patient outcomes. The company's business model revolves around the development, manufacturing, and sale of its proprietary medical devices. Revenue is generated through the direct sale of these devices to healthcare providers and through strategic partnerships. Avinger aims to revolutionize vascular disease treatment by providing innovative, image-guided solutions that reduce the need for more invasive surgical procedures.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2007
- Headquarters
- Redwood City, United States
- Listing
- IPO 2015
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Lucas Venture Group
Black Diamond Ventures- CLCRG LP
Zylox-Tonbridge Medical Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Avinger on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Avinger on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.